1245.20.86001 Boehringer Ingelheim Investigational Site
Guangzhou
0 studies enrolling now · 1 studies all time
What they study most
Diabetes Mellitus, Type 2
Studies at this site
Efficacy and Safety of Empagliflozin (BI 10773) Versus Placebo and Sitagliptin Over 24 Weeks in Patients With Type 2 Diabetes
— Completed